Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes

Chemotherapy

Volumn 44, Issue 1, 1998, Pages 42-49

  Braga, P C ^a,c   Sala, M T ^a   Mancini, L ^b   Dal Sasso, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Centro di Farmacologia Respiratoria   (Italy)

Author keywords

Fluorescence microscopy; Killing; Phagocytosis; Polymorphonuclear leukocytes; Rokitamycin

Indexed keywords

MACROLIDE; ROKITAMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADULT; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; HUMANS; MICROSCOPY, FLUORESCENCE; MIOCAMYCIN; NEUTROPHILS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 0031974184     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007089     Document Type: Article

References (33)

1. Shiritany Y, Saigusa M, Yokoiyama S, Mizuno K, Murase J: Effect of rokitamycin, a new macrolide antibiotic, on the killing activities of polymorphonuclear leukocytes or macrophage against S. aureus and C. jejuni. Proc 28th Intersci Conf Antimicrob Agents Chemother, Los Angeles, 1988, Abstr 907.
2. Labro MT: Effects of macrolides on host natural defences; in Bryskier AJ, Butzler JL, Neu HC, Tulkens PM (eds): Macrolides: Chemistry, Pharmacology and Clinical Use. Paris, Arnette Blackwell, 1993, pp 389-408.
3. 3H-Staphyloccus aureus by human macrophages. Microbios 1989;58: 17-25.
4. Privitera G, Ortisi G, Vigo B, Capsoni F: Effet de la josamycine sur les fonctions phagocytaires et microbicides des polymorphonucléaires humains. Méd Mal Infect 1985;spec issue josamycine):49-51.
5. Anderson R, Van Rensburg CEJ, Jooné G, Lukey FT: An in vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. J Antimicrob Chemother 1986;20(suppl B):57-68.
6. Carlier MB, Zenebergh A, Tulkens PM: Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J Antimicrob Chemother 1987; 20(suppl B):47-56.
7. Ishiguro M, Koga H, Kohno S, Hayashi T, Yamaguchi K, Hirota M: Penetration of macrolides into human polymorphonuclear leukocytes. J Antimicrob Chemother 1989;24:719-729.
8. Pocidalo JJ, Albert F, Desnottes JF, Kernbaum S: Intraphagocytic penetration of macrolides: In vivo comparison of erythromycin and spiramycin. J Antimicrob Chemother 1985;16(suppl A):167-173.
9. Wildfeuer A, Laufen H, Müller-Wening D, Haferkamp O: Interaction of azythromycin and human phagocytic cells: Uptake of the antibiotic and the effect on the survival of ingested bacteria. Arzneimittelforschung 1989;39:755-758.
10. Desnottes JF, Diallo N, Moret G, Santonia R: Effects of subinhibitory concentrations of pefloxacin on the adherence of S. aureus to human cells. Drug Exp Clin Res 1987;13: 69-73.
11. Braga PC: Effects of subinhibitory concentrations of seven macrolides and four fluoroquinolones on adhesion of Staphylococcus aureus to human mucosal cells. Chemotherapy 1994;40:304-310.
12. Braga PC, Dal Sasso M, Maci S, Reggio S, Piatti G: Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli. Chemotherapy 1995;41:50-58.
13. Yourtee RL, Root RK: Effect of antibiotics on phagocyte-microbe interactions; in Root RK, Sande MA (eds): New Dimensions in Antimicrobial Therapy. New York, Churchill Livingstone, 1984, pp 243-275.
14. Orlando R, Fragasso A, Benvenuti C, Okolicsany L: Pharmacokinetics of rokitamycin after single and repeat oral adiministration to patients with liver cirrhosis. Drug Invest 1991;3:162-166.
15. Morishita M, Suzuki T, Hayano K: In vivo behaviour of a new macrolide antibiotic, rokitamycin. Antibiot Chemother 1987;3:53-62.
16. Bellinati-Pires R, Melki SE, Colletto GMDD, Carneiro-Sampaio MMS: Evaluation of a fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions. J Immunol Methods 1989;119:189-196.
17. Hed J: The extinction of fluorescence by cristal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol Lett 1977; 1:357-361.
18. Goldner M, Farkas-Himsley H, Kormendy A, Skinner M: Bacterial phagocytosis monitored by fluorescence and extracellular quenching: Ingestion and intracellular killing. Lab Med 1983;14:291-294.
19. Smith DL, Rommel F: A rapid micromethod for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro. J Immunol Methods 1977;17:241-247.
20. Prieto-Prieto J, Minguez F, Ortega P, Corrales I, Ledesma V: Comparative study of the effects of roxithromycin and other macrolides on polymorphonuclear white cells in vitro. Br J Clin Pract 1988;42 (suppl 55):38-39.
21. Fietta A, Bersani C, Santagada T, Bertoletti R, Gialdroni Grassi G: In vitro activity of macrolides on human phagocytic functions. Chemiotherapia 1987;6:52-55.
22. Mascellino MT, DeVito ML, MacLean Feeney E, Iegri F, Catania S: Phagocytosis and killing of A-protein positive Staphylococcus aureus in the presence of low doses of antibiotics. Drugs Exp Clin Res 1989; 15:63-69.
23. Cuffini AM, Carlone NA, Tullio V, Barsotto M: Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 3. Killing of intracellular Staphylococcus aureus by human macrophages. Microbios 1989;58:27-33.
24. Burgaleta C, Perans M, Martinex-Beltran J, Herrero D: Effects of clarithromycin on phagocytosis and bactericidal activity of human polymorphonuclear leukocytes. 1st Int Conf Macrolides Azalides Streptogramins, Santa Fé, 1992, Abstr 1976.
25. Desnottes JF, Diallo N, Correia C: Effect of josamycin on adhesiveness and phagocytosis of gram-positive cocci. Proc 4th Eur Congr Clin Microbiol, Nice, 1989, Abstr 377.
26. Forsgren A, Schmeling D: Effect of antibiotics on chemotaxis of human leukocytes. Antimicrob Agents Chemother 1977;11:580-584.
27. Esterly NB, Furey NL, Flanagan LE: The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978;70:51-55.
28. Anderson R: Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 1989;159:966-973.
29. Myachi Y, Yoshioka A, Imamura S, Niwa Y: Effects of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986;86: 449-453.
30. Hand WL, Hand DL, King-Thompson NL: Antibiotic inhibition of the respiratory burst response in human polymorphonudear leukocytes. Antimicrob Agents Chemother 1990; 34:863-870.
31. Lianou PE, Bassaris HP, Vlachodimitropoulos D, Papavassiliou JT: Effect of subinhibitory concentrations of roxithromycin on polymorphonuclear leucocytes function against gram-positive aerobic organism. Proc 16th ICC, Jerusalem, 1989, Abstr 215.
32. Roszkowski K, Beuth J, Ko HL, Peters G, Pulverer G: Comparative study on the macrolides erythromycin and clarithromycin: Antibacterial activity and influence on immune response. Zentralbl Bakteriol 1990;273:518-530.
33. McDonald PJ, Pruul H: Unexpected synergy between azithromycin and humoral factors in opsonophagocytic killing. Proc 30th ICAAC, Atlanta, 1990, Abstr 883.